期刊文献+

MTRR A66G、MSD919G、MTHFR C677T基因多态性与脑梗死的关系 被引量:4

The relationship between gene polymorphisms of MTRR A66G, MS D919G, MTHFR C677T and cerebral infarction
原文传递
导出
摘要 目的探讨MTRRA66G、MSD919G、MTHFRC677T基因多态性与脑梗死的关系。方法选择136例脑梗死(CI)患者和70例对照,用PCR-RFLP方法分析其MTRR、MS和MTHFR基因型。结果CI组和对照组的MTRRA66G多态性的分布差异无显著性意义(χ2=1.645,P=0.439);CI组与对照组相比,MSD919G各基因型的频率差异无显著性意义(χ2=1.040,P=0.595);两组的MTHFRC677T各基因型的频率差异也没有显著性意义(χ2=1.399,P=0.497)。结论通过实验推测MTRRA66G、MSD919G、MTHFRC677T基因多态性不是CI的独立遗传危险因素。 Objectives To analyze the relationship between gene polymorphisms of MTRR A66G, MS D919G, MTHFR C677T and cerebral infarction (CI). Methods 136 CI patients confirmed by cranial CT or MRI were involved into the study and 70 subjects without stroke into control group. Gene polymorphisms ofMTRR A66G, MS D919G, MTHFR C677T were detected by PCR-RFLP technique. Results There was no statistically significant difference in the distribution of the MTRR genotypes between CI and controls (X^2=1.645 ,P〉0.05). No difference was found in the gene frequency of the MS genotypes between CI and controls (X^2=1.040 ,P〉0.05). There was no difference in the gene frequency of MTHFR genotypes between CI and controls (X^2=1.399 ,P〉0.05). Conclusions Gene polymorphisms of MTRR A66G, MS D919G, MTHFR C677T may not be independent genetical risk factors of CI.
出处 《中华神经医学杂志》 CAS CSCD 2005年第9期902-904,907,共4页 Chinese Journal of Neuromedicine
基金 广东省自然科学基金(31776)
关键词 脑梗死 基因 多态性 同型半胱氨酸 高同型半胱氨酸血症 Cerebral infarction Gene Polymorphisms Homocysteine Hyperhomo-cysteinemia
  • 相关文献

参考文献19

  • 1Kelly PJ, Rosand J, Kistler JP, et al. Homocysteine, MTHFR 677C-->T polymorphism, and risk ofischemic stroke: results of a meta-analysis[J]. Neurology, 2002, 59(4): 529-536.
  • 2邓兵梅,徐恩,谢海峰.急性脑梗死患者血浆同型半胱氨酸水平及意义[J].中国慢性病预防与控制,2004,12(6):248-250. 被引量:10
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 4LeclercD, WilsonA, DumasR, etal. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein in defective in patients with homocystinuria[J]. Proc Natl Acad Sci USA, 1998,95(6): 3059-3064.
  • 5Leclerc D, Campeau E, Goyette P, et al. Human methionine symthase:cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders[J]. Hum Mol Genet, 1996, 5(12): 1867-1874.
  • 6许海燕,陈在嘉,汤健,姜玉新,张晨晖,朱大明,张春玲,叶珏,赵如冰,杨跃进,陈纪林,惠汝太.冠心病患者同型半胱氨酸代谢相关酶基因多态性的研究[J].中华医学杂志,1999,79(6):414-416. 被引量:30
  • 7Brown CA, McKinney KQ, Kaufman JS, et al. A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease[J]. J Cardiovasc Risk, 2000, 7(3):197-200.
  • 8Gaughan DJ, Kluijtmans LA, Barbaux S, et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations [J].Atherosclerosis, 2001, 157(2): 451-456.
  • 9Wilson A, platt R, Wu Q, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12)increases risk for spina bifida [J]. Mol Genet Metab, 1999, 67(4):317-323.
  • 10Ray JG, Langman LJ, Vermeulen MJ, et al. Genetics university of Toronto thrombphilia study in women (GUTTSI): genetic and other risk factors for venous thromboembolism in women[J]. Curr Control Trials Cardiovasc Med, 2001, 2(3): 141-149.

二级参考文献8

  • 1Willems FF, Aengevaeren WR, Boers GH, et aL Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease [J]. J Am Coll Cardiol,2002,40:766-772.
  • 2Hogeveen M, Blom HJ, Van Amerongen M, et al. Hyperhomocysteinemia as risk factor for ischemic and hemorrhagic stroke in newborn infants[J]. J Pediatr,2002,141:429-431.
  • 3Aronow WS, Ahn C, Gutstein H. Increased plasma homocysteine is an independent predictor of new atherothrombotic brain infarction in older persons[J]. Am J Cardiol,2000,86:585-586.
  • 4Yoo JH, Chung CS, Kan SS. Relation of plasma homocysteine to cerebral infarction and cerebral atherosclerosis[J]. Stroke,1998,29:2478-2483.
  • 5Woo KS, Chook P, Chan LL, et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation[J]. Am J Med,2002,112: 535-539.
  • 6David S Wald, Malcolm Law, Joan K Morris. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis [J]. BMJ,2002,325:1-7.
  • 7黄其擎,世界医学杂志,1999年,3卷,50页
  • 8黄其擎,惠汝太.高压液相层析法测定血浆同型半胱氨酸及其初步应用[J].世界医学杂志,1999,3(1):50-52. 被引量:23

共引文献33057

同被引文献48

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部